EndoQuest to Install Surgical Robot System at Boston Hospital

[Image from EndoQuest’s website]

EndoQuest Robotics today announced that its proprietary surgical robot system will be installed at a major Boston hospital.

Houston-based EndoQuest’s Endoluminal Surgical System (ELS) will be installed at Brigham and Women’s Hospital (BWH) in Boston.

It is the world’s first endoluminal surgical robotic system for scarless upper and lower gastrointestinal surgery, according to a press release. The platform allows therapeutic endoscopists and surgeons to operate trans-oral or trans-anal.

EndoQuest is one of MassDevice’s 16 surgical robotics companies you need to know about. READ HERE

EndoQuest describes its system as an innovative advance in minimally invasive surgery. She designed the ELS system to combine the flexibility of conventional endoscopy with the advantages of traditional surgical techniques.

“Successful endoluminal surgery requires innovation in technology and procedural techniques”, said dr. Christopher Thompson, p.Professor of Medicine and Director of Endoscopy, Brigham and Women’s Hospital. “The EndoQuest system is the world’s first fully robotic platform specifically designed for gastrointestinal tract surgery and can enable endoscopists to perform many procedures that are very difficult or impossible today.”

The technology enables a range of surgeries by directly accessing disease target sites through existing lumens. The design includes a proprietary endoscope serving as a flexible, steerable overtube supporting two surgical instruments and a videoscope.

EndoQuest’s ELS performs minimally invasive procedures using internal incisions that do not result in visible scarring. EndoQuest said its system offers new levels of precision and control for techniques that weren’t possible before.

“We are very pleased to partner with Brigham and Women’s Hospital, a global leader in endoluminal surgery innovation, and look forward to working with them to advance the clinical and procedural development of the ELS System,” said Kurt Azarbarzin, CEO of EndoQuest Robotics. “We also hope to expand this relationship to include BWH as the center of our IDE clinical study scheduled for late 2023 and as the first center of excellence and training center in the United States”

Christine E. Phillips